TARGETING LYSOSOMAL TRANSIENT RECEPTOR POTENTIAL CHANNEL MUCOLIPIN-1 TO TREAT NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY
$314,510FY2020Defense Health AgencyDOD
Trustees Of Indiana University, Bloomington IN
Trustees Of Indiana University, Bloomington IN